EDITORIAL
Accepted on 13 Oct 2025
Editorial: Immunotherapy and Cell Therapy for Patients with Relapsed and Refractory Acute Myeloid Leukemia
doi 10.3389/fonc.2025.1691911
- 128 views
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- Immunotherapy and Cell Therapy for Patients with Relapsed and Refractory Acute Myeloid Leukemia
Immunotherapy and Cell Therapy for Patients with Relapsed and Refractory Acute Myeloid Leukemia
5,176
Total downloads
15k
Total views and downloads
Articles
REVIEW
Published on 04 Dec 2024
Updates in novel immunotherapeutic strategies for relapsed/refractory AML
doi 10.3389/fonc.2024.1374963
- 3,136 views
- 5 citations
CASE REPORT
Published on 13 Jun 2024
Case report: Clinical features of pediatric acute myeloid leukemia presenting with cardiac tamponade: a case series study and literature review
doi 10.3389/fonc.2024.1391768
- 1,444 views
CASE REPORT
Published on 23 Jan 2024
Sequential autologous CAR-T and allogeneic CAR-T therapy successfully treats central nervous system involvement relapsed/refractory ALL: a case report and literature review
doi 10.3389/fonc.2024.1341682
- 1,950 views
- 1 citation
ORIGINAL RESEARCH
Published on 20 Nov 2023
Venetoclax combined with hypomethylating agents and the CAG regimen in relapsed/refractory AML: a single-center clinical trial
doi 10.3389/fimmu.2023.1269163
- 2,551 views
- 5 citations
CASE REPORT
Published on 28 Sep 2023
Demethylating agents in combination with CD7-targeted CAR-T for the successful treatment of a case with mixed-phenotype acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation: A Case Report
doi 10.3389/fimmu.2023.1254010
- 1,993 views
- 2 citations
